반응식
[C:1]([C:6]1[C:7](=[O:28])[CH2:8][CH:9]([C:13]2[C:18]([CH3:19])=[CH:17][C:16]([CH3:20])=[C:15]([CH2:21][S:22][CH2:23][CH2:24][CH2:25][CH3:26])[C:14]=2[CH3:27])[CH2:10][C:11]=1[OH:12])(=O)[CH2:2][CH2:3][CH3:4].Cl.[CH2:30]([O:32][NH2:33])[CH3:31]>>[CH2:23]([S:22][CH2:21][C:15]1[C:14]([CH3:27])=[C:13]([CH:9]2[CH2:10][C:11](=[O:12])[C:6]([C:1](=[N:33][O:32][CH2:30][CH3:31])[CH2:2][CH2:3][CH3:4])=[C:7]([OH:28])[CH2:8]2)[C:18]([CH3:19])=[CH:17][C:16]=1[CH3:20])[CH2:24][CH2:25][CH3:26]참가 물질
3
실험 절차
5-[3-(n-Butylthiomethyl)-2,4,6-trimethylphenyl]-2-[1-(ethoxyimino)butyl]-3-hydroxycyclohex-2-en-1-one (59) was prepared from 2-butyryl-5-[3-(n-butylthiomethyl)-2,4,6-trimethylphenyl]-3-hydroxycyclohex-2-en-1-one and ethoxyamine hydrochloride following essentially the same procedure as that described in Example 1, part (iv).
출처 및 근거
- ORD 기록
- ord-add4263e916e4d10b749dbf163e97500
- 출처 데이터셋
- uspto-grants-1988_08
- 특허 번호
- US04767879
연결된 노트
불러오는 중…